Ebba Carbonnier Portfolio Manager for Nationally Scalable Solutions at Swelife, a Strategic Innovation Programme within Life Science. Examples of some of the national projects within the portfolio are Cell- and Gene Therapy, Biobanking and Prevention of childhood obesity. Carbonnier was previously KI’s Programme Leader for a joint programme between KI and Stockholm County Council. The programme aimed to improve conditions for healthcare and research to enable the rapid transfer of knowledge to personalized prevention and treatment. Key components in the solutions delivered were semantic interoperability, standardized outcome measures and digitization. The programme encompassed five projects and 25 subprojects within the areas of Arthritis, Breast cancer, Diabetes and Heart Failure. Prior to KI, Carbonnier has 14 years of Management Consulting experience, ranging from daily management of teams to creating and implementing strategies for global companies. Managing large scale multinational projects at e.g. AstraZeneca, Microsoft and Sandvik, is an area where Carbonnier has extensive experience. Carbonnier holds an MSc and an MBA with a focus on Operations Management. Having lived/studied/worked in five countries apart from Sweden, has given Carbonnier an ability to handle situations and create results in complex environments. Carbonnier is also a guest lecturer at the Swedish Royal Institute of Technology (KTH) within System Engineering. Carbonnier, Göran Johansson and Per Sikora initiated a collaboration between WACQT, GMS and Swelife in the beginning of 2019 with the purpose of starting to identify Quantum Algorithms suitable for Metagenomics within Life Sciences. Focus in the long run is on Preventative Health in a Healthy-Risk-Ill perspective so that we do not merely go on spending 97% of resources in the healthcare sector on the Ill part.